Advances in drug therapy of gastroesophageal reflux disease
Author(s)
Bibliographic Information
Advances in drug therapy of gastroesophageal reflux disease
(Frontiers of gastrointestinal research, vol. 20)
Karger, 1992
- : alk. paper
Available at 5 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
Gastroesophageal reflux disease (GERD) is a very common disorder bringing a large number of patients to physicians every day. In the early 1970s the treatment of the disease consisted mainly of antacid and lifestyle modifications, but recently developed agents have changed the management strategy. The many drugs available today create some difficulty for the physician who must write a prescription for his or her patient. This reference source will help physicians to make a rational choice from the available therapeutic options by reviewing in detail the evidence relating to individual drugs used in the medical treatment of GERD. The chapters describe the pharmacological profile and mechanism of action of currently available motor-stimulating and acid-lowering agents and also evaluate their place in the management of GERD. In addition, the role of mucosal protective agents in therapy is considered.
Table of Contents
- Motor-stimulating drugs
- acid-lowering drugs
- mucosal protective agents
- special topics.
by "Nielsen BookData"